Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
Operating Expenses | 3,813 | 2,612 | 2,326 | 1,880 | 1,071 |
Operating Income | -3,813 | -2,612 | -2,326 | -1,880 | -1,071 |
Other Income | -14 | 0 | 3 | 3 | -2 |
Pre-tax Income | -3,827 | -2,612 | -2,323 | -1,877 | -1,073 |
Net Income Continuous | -3,827 | -2,612 | -2,323 | -1,877 | -1,073 |
Net Income | $-3,827 | $-2,612 | $-2,323 | $-1,877 | $-1,073 |
EPS Basic Total Ops | -0.15 | -0.11 | -0.09 | -0.08 | -0.05 |
EPS Basic Continuous Ops | -0.15 | -0.11 | -0.10 | -0.08 | -0.05 |
EPS Diluted Total Ops | -0.15 | -0.11 | -0.09 | -0.08 | -0.05 |
EPS Diluted Continuous Ops | -0.15 | -0.11 | -0.10 | -0.08 | -0.05 |
EPS Diluted Before Non-Recurring Items | -0.15 | -0.11 | -0.10 | N/A | N/A |
EBITDA(a) | $-3,813 | $-2,612 | $-2,326 | $-1,880 | $-1,071 |